Pascal Touchon - 17 May 2022 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
19 May 2022, 17:04:41 UTC
Prior SEC filing
03 Mar 2022
Next SEC filing
29 Jun 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ David Tucker, Attorney-in-Fact for Pascal Touchon

Key filing fact

Pascal Touchon filed Form 4 for Atara Biotherapeutics, Inc. (ATRA) on 19 May 2022.

Key facts

  • This page summarizes Pascal Touchon's Form 4 filing for Atara Biotherapeutics, Inc. (ATRA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 19 May 2022, 17:04.

Change

  • Previous filing in this sequence was filed on 03 Mar 2022.
  • Current net transaction value: -$73,962.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATRA transaction

Common Stock

Sale

Transaction value
$73,962
Shares
-13,913
Change %
-2.8%
Price
$5.32
Shares after
486,313
Date
17 May 2022
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted restricted stock units.

Footnote F2

The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 17, 2022 and May 18, 2022 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .